SGLT2 Inhibitor-Linked Diabetic Ketoacidosis Is Rare, but Severe SGLT2 Inhibitor-Linked Diabetic Ketoacidosis Is Rare, but Severe

A series of Australian cases of DKA linked to SGLT2 inhibitors confirms the side effect is rare but severe. Most cases had identifiable precipitators.Medscape Medical News

Source: Medscape Medical News Headlines - February 21, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news